Description     Claims     Drawing  

US4683195A   [0027] 
WO2012058458A   [0039]  [0064] 
WO2013009525A   [0039] 
US6010613A   [0110] 
WO2004083379A   [0110] 
US6352694B   [0114] 
US6534055B   [0114] 
US6905680B   [0114] 
US6692964B   [0114] 
US5858358A   [0114] 
US6887466B   [0114] 
US6905681B   [0114] 
US7144575B   [0114] 
US7067318B   [0114] 
US7172869B   [0114] 
US7232566B   [0114] 
US7175843B   [0114] 
US5883223A   [0114] 
US6905874B   [0114] 
US6797514B   [0114] 
US6867041B   [0114] 
US20060121005   [0114] 
FR901228   [0133] 
WO2012138927A   [0140] 
US4474893A   [0142] 
WO2013017950A   [0149] 
WO2004067736A   [0150]  [0150] 

BLOOD   [0004] 
Current Protocols in Molecular Biology   [0027] 
Molecular Cloning: A Laboratory Manual   [0027] 
Oligonucleotide Synthesis   [0027] 
Nucleic Acid Hybridization   [0027] 
Transcription And Translation   [0027] 
Culture Of Animal Cells   [0027] 
Immobilized Cells And Enzymes   [0027] 
A Practical Guide To Molecular Cloning   [0027] 
Methods In ENZYMOLOGY   [0027] 
Gene Expression Technology   [0027] 
Gene Transfer Vectors For Mammalian Cells   [0027] 
Immunochemical Methods In Cell And Molecular Biology   [0027] 
Handbook Of Experimental Immunology   [0027] 
Manipulating the Mouse Embryo   [0027] 
J. of General Virology   [0106] 
J. of Gen. Virology   [0106] 
Mol. And. Cell. Biology   [0106] 
RNA   [0106] 
Cell   [0133] 
Immun   [0133] 
Citrr. Opin. mm n.   [0133] 
Retroviridae: The viruses and their replication   [0136] 
Proc. Natl. Acad. Sci. USA   [0142] 
Exploring the cellular activity of camptothecin-triple-helix-forming oligonucleotide conjugates   [0205] 
Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets   [0205] 
Genetic and mutational analysis of the T-cell antigen receptor   [0205] 
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation   [0205] 
Breaking the code of DNA binding specificity of TAL-type III effectors   [0205] 
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.   [0205] 
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates   [0205] 
Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM)   [0205] 
An endoplasmic reticulum retention function for the cytoplasmic tail of the human pre-T cell receptor (TCR) alpha chain: potential role in the regulation of cell surface pre-TCR expression levels   [0205] 
Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting   [0205] 
In vivo selection of engineered homing endonucleases using double-strand break induced homologous recombination   [0205] 
Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae   [0205] 
Targeting DNA double-strand breaks with TAL effector nucleases   [0205] 
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights   [0205] 
DNA end-joining: from yeast to man   [0205] 
Structural basis for sequence-specific recognition of DNA by TAL effectors   [0205] 
Developing a programmed restriction endonuclease for highly specific DNA cleavage   [0205] 
A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells   [0205] 
Transcriptional activators of human genes with programmable DNA-specificity   [0205] 
CD3 zeta subunit can substitute for the gamma subunit of Fc epsilon receptor type I in assembly and functional expression of the high-affinity IgE receptor: evidence for interreceptor complementation   [0205] 
Heritable gene targeting in zebrafish using customized TALENs   [0205] 
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor   [0205] 
Targeted genome modification via triple helix formation   [0205] 
Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modification   [0205] 
TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and Fokl DNA-cleavage domain   [0205] 
Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes   [0205] 
Yeast Mre11 and Rad1 proteins define a Ku-independent mechanism to repair double-strand breaks lacking overlapping end sequences   [0205] 
Targeted transcriptional repression using a chimeric TALE-SRDX repressor protein   [0205] 
De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks   [0205] 
The crystal structure of TAL effector PthXo1 bound to its DNA target   [0205] 
The receptor with high affinity for immunoglobulin E   [0205] 
A TALE nuclease architecture for efficient genome editing   [0205] 
Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors   [0205] 
A simple cipher governs DNA recognition by TAL effectors   [0205] 
A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity   [0205] 
The structural basis for autonomous dimerization of the pre-T-cell antigen receptor   [0205] 
Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy   [0205] 
Immunotherapy earns its spot in the ranks of cancer therapy   [0205] 
The blockade of immune checkpoints in cancer immunotherapy   [0205] 
Treating cancer with genetically engineered T cells   [0205] 
Precision genome surgery   [0205] 
Gene targeting using zinc finger nucleases   [0205] 
Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanoma   [0205] 
Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease   [0205] 
Genomic structure of the human pre-T cell receptor alpha chain and expression of two mRNA isoforms   [0205] 
Targeted gene disruption in somatic zebrafish cells using engineered TALENs   [0205] 
A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences   [0205] 
Homing endonuclease structure and function   [0205] 
Knockout rats generated by embryo microinjection of TALENs   [0205] 
Unique features of the pre-T-cell receptor alpha-chain: not just a surrogate   [0205] 
CAMPATH: from concept to clinic   [0205] 
Assembly of designer TAL effectors by Golden Gate cloning   [0205] 
Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development   [0205] 
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription   [0205]